• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.2008 年至 2012 年中国北京地区大环内酯类耐药肺炎支原体的监测。
Antimicrob Agents Chemother. 2013 Mar;57(3):1521-3. doi: 10.1128/AAC.02060-12. Epub 2012 Dec 21.
2
Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.中国北京 40 株肺炎支原体分离株的抗生素敏感性及大环内酯类耐药株的分子分析。
Antimicrob Agents Chemother. 2012 Feb;56(2):1108-9. doi: 10.1128/AAC.05627-11. Epub 2011 Nov 21.
3
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.中国肺炎支原体临床分离株大环内酯类耐药的分子机制
Antimicrob Agents Chemother. 2009 May;53(5):2158-9. doi: 10.1128/AAC.01563-08. Epub 2009 Mar 9.
4
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].[中国北京成年社区获得性肺炎患者肺炎支原体大环内酯类耐药性调查]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):954-8.
5
Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.韩国肺炎支原体大环内酯类耐药性,2000-2011 年。
Emerg Infect Dis. 2013 Aug;19(8):1281-4. doi: 10.3201/eid1908.121455.
6
Antimicrobial susceptibility and genotyping of isolates in Beijing, China, from 2014 to 2016.2014 年至 2016 年期间中国北京分离株的抗菌药物敏感性和基因分型。
Antimicrob Resist Infect Control. 2019 Jan 24;8:18. doi: 10.1186/s13756-019-0469-7. eCollection 2019.
7
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.日本 2008-2015 年耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
8
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.中国上海肺炎支原体分离株的抗菌药敏性及大环内酯类耐药菌株的分子分析
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.
9
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
10
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.6 岁男孩患耐大环内酯类肺炎支原体所致重症社区获得性肺炎。
Hong Kong Med J. 2011 Oct;17(5):407-9.

引用本文的文献

1
Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study.23S rRNA A2063G突变所致重症大环内酯类耐药肺炎支原体肺炎的临床特征及危险因素:一项回顾性观察研究
Eur J Clin Microbiol Infect Dis. 2025 Jul 17. doi: 10.1007/s10096-025-05215-4.
2
Epidemiological changes of among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.2017年至2024年中国河南省儿童在新冠疫情之前、期间及之后的流行病学变化。
Microbiol Spectr. 2025 Jul;13(7):e0312124. doi: 10.1128/spectrum.03121-24. Epub 2025 Jun 9.
3
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.全球肺炎支原体近期的大环内酯类耐药模式:一项系统评价与Meta分析
Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246.
4
Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia.肺炎支原体肺炎患儿发热持续时间的治疗方式
Sci Rep. 2025 Apr 28;15(1):14860. doi: 10.1038/s41598-025-99537-0.
5
Characterizing the epidemiology of infections in China in 2022-2024: a nationwide cross-sectional study of over 1.6 million cases.描绘2022 - 2024年中国感染病流行病学特征:一项针对超160万病例的全国性横断面研究。
Emerg Microbes Infect. 2025 Dec;14(1):2482703. doi: 10.1080/22221751.2025.2482703. Epub 2025 Apr 6.
6
Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.中国重庆 COVID-19 大流行限制前后住院儿童肺炎支原体的流行病学特征。
Front Cell Infect Microbiol. 2024 Aug 16;14:1424554. doi: 10.3389/fcimb.2024.1424554. eCollection 2024.
7
Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.儿童大环内酯类耐药肺炎支原体肺炎诊断与治疗专家共识。
World J Pediatr. 2024 Sep;20(9):901-914. doi: 10.1007/s12519-024-00831-0. Epub 2024 Aug 14.
8
A study on viruses and bacteria with particular interest on Mycoplasma pneumoniae in children with exacerbation of asthma from a tertiary care hospital in Sri Lanka.一项针对斯里兰卡一家三级护理医院中哮喘加重患儿的病毒和细菌的研究,尤其关注肺炎支原体。
Access Microbiol. 2024 Jul 30;6(7). doi: 10.1099/acmi.0.000778.v5. eCollection 2024.
9
Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of HPrK/P.基于结构的虚拟筛选、ADMET性质预测及分子动力学研究揭示了HPrK/P的潜在抑制剂
Life (Basel). 2024 May 22;14(6):657. doi: 10.3390/life14060657.
10
Effectiveness of the six-step approach guided online training program to improve knowledge of pneumonia among pediatricians: a pretest-posttest study.六步指导在线培训项目提高儿科医生肺炎知识的效果:一项前后测研究
Transl Pediatr. 2024 May 31;13(5):760-769. doi: 10.21037/tp-24-53. Epub 2024 May 24.

本文引用的文献

1
Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011.2008 年至 2011 年期间,从中国北京的 201 株肺炎支原体分离株中进行多位点可变数串联重复分析。
J Clin Microbiol. 2013 Feb;51(2):636-9. doi: 10.1128/JCM.02567-12. Epub 2012 Dec 5.
2
Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.中国北京 40 株肺炎支原体分离株的抗生素敏感性及大环内酯类耐药株的分子分析。
Antimicrob Agents Chemother. 2012 Feb;56(2):1108-9. doi: 10.1128/AAC.05627-11. Epub 2011 Nov 21.
3
Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009.2008 年至 2009 年北京临床分离株肺炎支原体 p1 黏附素基因的序列分析。
J Clin Microbiol. 2011 Aug;49(8):3000-3. doi: 10.1128/JCM.00105-11. Epub 2011 Jun 22.
4
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.中国成人和青少年呼吸道感染肺炎支原体分离株中大环内酯类耐药率高。
Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.
5
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.法国人类李斯特菌分离株的抗菌耐药性。
Antimicrob Agents Chemother. 2010 Jun;54(6):2728-31. doi: 10.1128/AAC.01557-09. Epub 2010 Apr 12.
6
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.德国大环内酯类耐药肺炎支原体株的发生情况。
Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.
7
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.通过实时聚合酶链反应和熔解曲线分析直接在临床标本中检测到法国肺炎支原体对大环内酯类药物的耐药性增加。
J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.
8
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.中国肺炎支原体临床分离株大环内酯类耐药的分子机制
Antimicrob Agents Chemother. 2009 May;53(5):2158-9. doi: 10.1128/AAC.01563-08. Epub 2009 Mar 9.
9
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.中国上海肺炎支原体分离株的抗菌药敏性及大环内酯类耐药菌株的分子分析
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.
10
New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.肺炎支原体感染的发病机制与检测新见解
Future Microbiol. 2008 Dec;3(6):635-48. doi: 10.2217/17460913.3.6.635.

2008 年至 2012 年中国北京地区大环内酯类耐药肺炎支原体的监测。

Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

机构信息

National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.

出版信息

Antimicrob Agents Chemother. 2013 Mar;57(3):1521-3. doi: 10.1128/AAC.02060-12. Epub 2012 Dec 21.

DOI:10.1128/AAC.02060-12
PMID:23263003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3591905/
Abstract

Macrolide resistance rates of Mycoplasma pneumoniae in the Beijing population were as high as 68.9%, 90.0%, 98.4%, 95.4%, and 97.0% in the years 2008 to 2012, respectively. Common macrolide-resistant mobile genetic elements were not detected with any isolate. These macrolide-resistant isolates came from multiple clones rather than the same clone. No massive aggregation of a particular clone was found in a specific period.

摘要

2008 年至 2012 年,北京地区肺炎支原体大环内酯类耐药率分别高达 68.9%、90.0%、98.4%、95.4%和 97.0%。未检测到任何分离株携带常见的大环内酯类耐药移动遗传元件。这些耐药分离株来自多个克隆体,而非同一个克隆体。在特定时期,未发现特定克隆体的大规模聚集。